Pharmacological Activation of a Novel P53-Dependent S-Phase Checkpoint Involving CHK-1

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2011.42
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CHK-Ing in and CHK-Ing Out: Kinase Compartmentalization Comes to Checkpoint Control

Molecular Cell
Cell BiologyMolecular Biology
2010English

P53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Four Pillars of the S-Phase Checkpoint

Genes and Development
GeneticsDevelopmental Biology
2013English

Inhibition of Checkpoint Kinase 1 Following Gemcitabine-Mediated S Phase Arrest Results in CDC7- And CDK2-dependent Replication Catastrophe

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2018English

Multiple Functions of the S-Phase Checkpoint Mediator

Bioscience, Biotechnology and Biochemistry
Organic ChemistryApplied MicrobiologyMolecular BiologyBiochemistryAnalytical ChemistryMedicineBiotechnology
2010English

ERK Activity Facilitates Activation of the S-Phase DNA Damage Checkpoint by Modulating ATR Function

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Cdk1 Participates in BRCA1-Dependent S Phase Checkpoint Control in Response to DNA Damage

Molecular Cell
Cell BiologyMolecular Biology
2009English

Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a P53-Dependent Checkpoint

Journal of Immunology
AllergyImmunology
2014English

Perturbation of 60 S Ribosomal Biogenesis Results in Ribosomal Protein L5- And L11-Dependent P53 Activation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy